|
|
|
41
|
B2256
|
NOVOMIX 70|30 FLEXPENS 100U/ML INJ (NOV) ASPART
|
INSULIN ASPART
|
NOVOMIX 70|30 FLEXPENS
|
5X3ML
|
A
|
122.32
|
24.464
|
BOX
|
2
|
VIAL
|
NOV
|
NOVO NORDISK A/S
|
COL
|
COLLINS LTD
|
B
|
682008
|
INSULINS
|
2024-04-01
|
2026-03-31
|
|
SC
|
6
|
INSULINS
|
2024-03-05
|
|
|
|
42
|
B2256
|
NOVOMIX 70|30 FLEXPENS 100U/ML INJ (NOV) INSULIN ASPART
|
INSULIN ASPART
|
NOVOMIX 70|30 FLEXPENS
|
5X3ML
|
A
|
122.32
|
24.46
|
BOX
|
2
|
VIAL
|
NOV
|
NOVO NORDISK A/S
|
COL
|
AVENTA BARBADOS
|
B
|
682008
|
INSULINS
|
2026-04-01
|
2028-03-31
|
|
SC
|
6
|
INSULINS
|
|
|
|
|
41
|
B2258
|
HUMALOG 75%|25% INJ (LIL) INSULIN ISOPHANE|INSULIN REGULAR (C)
|
INSULIN ISOPHANE|INSULIN RAPID
|
HUMALOG
|
5X3ML
|
C
|
134.69
|
26.9386
|
VIAL
|
0
|
BOX
|
LIL
|
ELI LILLY S.A.(PUERTO RICO BRA)
|
STO
|
BRYDEN STOKES LTD
|
|
682008
|
INSULINS
|
2024-04-01
|
2026-03-31
|
|
SC
|
0
|
INSULINS
|
|
|
|
|
40
|
B225A
|
HUMULIN CARTRIDGE 70% | 30% INJ (LIL/STO) INSULIN ISOPHANE | INSULIN REGULAR
|
INSULIN ISOPHANE|INSULIN REGULAR
|
HUMULIN CARTRIDGE
|
5X3ML
|
A
|
47.03
|
9.41
|
INJECTION
|
5
|
VIAL
|
LIL
|
ELI LILLY S.A.(PUERTO RICO BRA)
|
STO
|
BRYDEN STOKES LTD
|
B
|
682008
|
INSULINS
|
2022-04-01
|
2024-03-31
|
|
SC
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
B225A
|
HUMULIN CARTRIDGE 70%|30% INJ (LIL) INSULIN ISOPHANE|INSULIN (C)
|
INSULIN ISOPHANE|INSULIN REGULAR
|
HUMULIN CARTRIDGE
|
5X3ML
|
C
|
52.41
|
52.41
|
CAR
|
5
|
VIAL
|
LIL
|
ELI LILLY S.A.(PUERTO RICO BRA)
|
STO
|
BRYDEN STOKES LTD
|
|
682008
|
INSULINS
|
2024-04-01
|
2026-03-31
|
|
SC
|
6
|
INSULINS
|
|
|
|
|
40
|
B225B
|
NOVOLIN PENFIL 70% | 30% INJ (NOV/COL) INSULIN ISOPHANE | INSULIN REGULAR
|
INSULIN ISOPHANE|INSULIN REGULAR
|
NOVOLIN PENFIL
|
5X3ML
|
C
|
61.19
|
12.24
|
INJECTION
|
0
|
VIAL
|
NOV
|
NOVO NORDISK A/S
|
COL
|
COLLINS LTD
|
B
|
682008
|
INSULINS
|
2022-04-01
|
2024-03-31
|
|
SC
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
B225B
|
NOVOLIN PENFIL 70%|30% INJ (NOV) INSULIN ISOPHANE|INSULIN RE (C)
|
INSULIN ISOPHANE|INSULIN REGULAR
|
NOVOLIN PENFIL
|
5X3ML
|
C
|
61.16
|
12.2325
|
VIAL
|
5
|
BOX
|
NOV
|
NOVO NORDISK A/S
|
COL
|
COLLINS LTD
|
|
682008
|
INSULINS
|
2024-04-01
|
2026-03-31
|
|
SC
|
6
|
INSULINS
|
|
|
|
|
42
|
B225B
|
NOVOLIN PENFIL 70%|30% INJ (NOV) INSULIN ISOPHANE|INSULIN RE
|
INSULIN ISOPHANE|INSULIN REGULAR
|
NOVOLIN PENFIL
|
5X3ML
|
A
|
61.16
|
12.23
|
VIAL
|
5
|
VIAL
|
NOV
|
NOVO NORDISK A/S
|
COL
|
AVENTA BARBADOS
|
B
|
682008
|
INSULINS
|
2026-04-01
|
2028-03-31
|
|
SC
|
6
|
INSULINS
|
|
|
|
|
41
|
B225D
|
HUMALOG KWIKPEN 75%|25% INJ (LIL) INSULIN ISOPHANE|INSULIN R (C)
|
INSULIN ISOPHANE|INSULIN RAPID
|
HUMALOG KWIKPEN
|
5X3ML
|
C
|
139.29
|
27.8574
|
VIAL
|
0
|
BOX
|
LIL
|
ELI LILLY S.A.(PUERTO RICO BRA)
|
STO
|
BRYDEN STOKES LTD
|
B
|
682008
|
INSULINS
|
2024-04-01
|
2026-03-31
|
|
SC
|
6
|
INSULINS
|
|
|
|
|
42
|
B2711
|
TRAJENTA 5MG TAB (BOE) LINAGLIPTIN
|
LINAGLIPTIN
|
TRAJENTA
|
30'S
|
C
|
114.66
|
3.82
|
TAB
|
0
|
BLIS
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
40
|
B2712
|
GALVUS 50MG TAB (NVS/COL) VIDAGLIPTIN
|
VIDAGLIPTIN
|
GALVUS
|
56'S
|
B
|
32.62
|
0.58
|
TABLET
|
60
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
B2712
|
GALVUS 50MG TAB (NVS) VILDAGLIPTIN (C)
|
VILDAGLIPTIN
|
GALVUS
|
56'S
|
C
|
32.62
|
0.5825
|
TAB
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
B2712
|
GALVUS 50MG TAB (NVS) VILDAGLIPTIN
|
VILDAGLIPTIN
|
GALVUS
|
56'S
|
C
|
27.18
|
0.49
|
TAB
|
60
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
40
|
B2713
|
JANUVIA 50MG TAB (MSD/STO) SITAGLIPTIN
|
SITAGLIPTIN
|
JANUVIA
|
28'S
|
C
|
70.65
|
2.52
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
B2713
|
JANUVIA 50MG TAB (MSD) SITAGLIPTIN (C)
|
SITAGLIPTIN
|
JANUVIA
|
28'S
|
C
|
67.12
|
2.397
|
TAB
|
0
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
40
|
B2714
|
JANUVIA 100MG TAB (MSD/STO) SITAGLIPTIN
|
SITAGLIPTIN
|
JANUVIA
|
28'S
|
C
|
70.65
|
2.52
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
B2714
|
JANUVIA 100MG TAB (MSD) SITAGLIPTIN (C)
|
SITAGLIPTIN
|
JANUVIA
|
28'S
|
C
|
67.12
|
2.397
|
TAB
|
0
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
B271A
|
VILDALION 50MG TAB (STL) VIDAGLIPTIN
|
VILDAGLIPTIN
|
VILDALION
|
30'S
|
B
|
1.74
|
0.06
|
TAB
|
60
|
BLIS
|
STL
|
STALLION LABORATORIES
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
B271AQ
|
SITADIET 50MG TAB (JLP) SITAGLIPTIN
|
SITAGLIPTIN
|
SITADIET
|
10X10
|
C
|
14.68
|
0.15
|
TAB
|
0
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
41
|
B271E
|
REMEVIA 100MG TAB (REM) SITAGLIPTIN (C)
|
SITAGLIPTIN
|
REMEVIA
|
28'S
|
C
|
11.93
|
0.4262
|
TAB
|
0
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|